<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Endemicity of Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) coincides with profusion of a plant Euphorbia tirucalli in tropical Africa </plain></SENT>
<SENT sid="1" pm="."><plain>E. tirucalli contains 4-deoxyphorbol <z:chebi fb="21" ids="35701">ester</z:chebi> that enhances Epstein-Barr virus (EBV) <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> of B lymphocytes </plain></SENT>
<SENT sid="2" pm="."><plain>In this study, we found that 4-deoxyphorbol <z:chebi fb="21" ids="35701">ester</z:chebi> reduced EBV-specific cytotoxic T-cell function </plain></SENT>
<SENT sid="3" pm="."><plain>Furthermore, the B lymphocytes dually exposed to EBV and 4-deoxyphorbol <z:chebi fb="21" ids="35701">ester</z:chebi> were resistant to EBV-specific T cell cytotoxicity, through down-regulation of latent membrane protein 1 (LMP1), the major target to EBV-specific cytotoxic T-cells </plain></SENT>
<SENT sid="4" pm="."><plain>These immunologic findings strengthen the notion that E. tirucalli may be an important environmental risk factor for the genesis of African <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> </plain></SENT>
</text></document>